Search Results - "SCHOL, Jessie"

Phase I feasibility trial of carboplatin, paclitaxel, and gemcitabine in patients with previously untreated epithelial ovarian or primary peritoneal cancer: a Gynecologic Oncology Group study by Look, Katherine Y, Bookman, Michael A, Schol, Jessie, Herzog, Thomas J, Rocereto, Thomas, Vinters, Jennifer

“…Purpose. To determine the feasibility of administering a minimum of four cycles of carboplatin, paclitaxel, and gemcitabine (CPG) every 21 days without…”
Get full text

Phase I Trial of Concurrent Hyperfractionated Split Course Radiotherapy (HFx RT), Cisplatin (cDDP), and Paclitaxel in Patients with Recurrent, Previously Irradiated, or Treatment-Naiive Locally Advanced Upper Aerodigestive Malignancy by Langer, Corey, Duffy, Karen, Horwitz, Eric, Litwin, Samuel, Rosvold, Elizabeth, Schol, Jessie, Keenan, Eileen, Nicolaou, Nicos, Friedman, Craig, Ridge, John

“…Purpose : Phase I study to determine the maximally tolerated dose (MTD) of cisplatin (cDDP), paclitaxel (P), and concurrent split course hyperfractionated…”
Get full text

Phase I Trial of Concurrent Hyperfractionated Split Course Radiotherapy (HFx RT), Cisplatin (cDDP), and Paclitaxel in Patients with Recurrent, Previously Irradiated, or Treatment-Naïve Locally Advanced Upper Aerodigestive Malignancy by Langer, Corey J., Duffy, Karen, Horwitz, Eric M., Litwin, Samuel, Rosvold, Elizabeth, Schol, Jessie, Keenan, Eileen, Nicolaou, Nicos, Friedman, Craig D., Ridge, John A.

“…Purpose: Phase I study to determine the maximally tolerated dose (MTD) of cisplatin (cDDP), paclitaxel (P), and concurrent split course hyperfractionated (BID)…”
Get full text

Phase I and pharmacokinetic study of the farnesyltransferase inhibitor R115777 in combination with irinotecan in patients with advanced cancer by COHEN, Steven J, GALLO, James, PALMER, Peter A, WEINER, Louis M, MEROPOL, Neal J, LEWIS, Nancy L, ALPAUGH, R. Katherine, GENTNER, Louis, ROGATKO, André, YESLOW, Gwen, SCHOL, Jessie, VERHAEGHE, Tom, ZANNIKOS, Peter

“…R115777 is a selective, nonpeptidomimetic inhibitor of farnesyltransferase (FTase), an enzyme responsible for the post-translational modification of several…”
Get full text

Induction and Concurrent Paclitaxel/Carboplatin Every 3 Weeks with Thoracic Radiotherapy in Locally Advanced Non–Small-Cell Lung Cancer: An Interim Report by Movsas, Benjamin, Hudes, Richard S., Schol, Jessie, Millenson, Michael, Rosvold, Elizabeth, Nicolaou, Nicholas, Litwin, Samuel, Wang, Hao, Keenan, Eileen, Curran, Walter J., Langer, Corey J.

“…The paclitaxel/carboplatin combination has demonstrated promising activity in metastatic non–small-cell lung cancer (NSCLC); therefore, we mounted an…”
Get full text